RE: Gout and sodium-glucose cotransporter-2 inhibitors

Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):114-115. doi: 10.1002/pds.5380. Epub 2021 Nov 14.

Authors

Lars Christian Lund¹, Mikkel Højlund¹, Daniel Pilsgaard Henriksen², Jesper Hallas^{1

2}, Kasper Bruun Kristensen¹

Affiliations

¹ Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
² Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.

PMID: 34729863
DOI: 10.1002/pds.5380

No abstract available

Publication types

Letter
Comment

MeSH terms

Gout* / drug therapy
Humans
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors* / adverse effects

Substances

Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors